Comi, G., Alroughani, R., Boster, A. L., Bass, A. D., Berkovich, R., Fernández, Ó., . . . Traboulsee, A. (2019). Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies. Mult Scler.
Styl cytowania ChicagoComi, Giancarlo, et al. "Efficacy of Alemtuzumab in Relapsing-remitting MS Patients Who Received Additional Courses After the Initial Two Courses: Pooled Analysis of the CARE-MS, Extension, and TOPAZ Studies." Mult Scler 2019.
Styl cytowania MLAComi, Giancarlo, et al. "Efficacy of Alemtuzumab in Relapsing-remitting MS Patients Who Received Additional Courses After the Initial Two Courses: Pooled Analysis of the CARE-MS, Extension, and TOPAZ Studies." Mult Scler 2019.